|
|
 |
|
|
|
|
2. L Kirby. Quantification at clinical sites. Appl. Clin. Trials 5: 11: 2630, 1996. |
|
|
|
|
|
|
|
|
3. British Standards Institute. BS EN ISO 9002: 1994: Quality Systems: Model for quality assurance in production, installation and servicing. 1994. |
|
|
|
|
|
|
|
|
4. J Seddon. ISO 9000 implementation and value-added: Three case studies. Report available from Vanguard Consulting Ltd, via the author, 1996. |
|
|
|
|
|
|
|
|
5. L B Rose. Top management attitudes to clinical research performance in the pharmaceutical industry. Internal Report, Medical Scientific Services Ltd., 1994. |
|
|
|
|
|
|
|
|
6. H Glass. How to get accurate information so that you can effectively benchmark your R & D success. Proceedings of IIR Ltd Conference on Measurement of Performance in Pharmaceutical R & D, October 1996. Reported in Pharm. Physician 8: 3: 2734, 1996. |
|
|
|
|
|
|
|
|
7. C Petersen. New strategies for academic medical centers. Appl. Clin. Trials 5: 8: 3340, 1996. |
|
|
|
|
|
|
|
|
8. M Hale, W R Gillespie, S K Gupta et al. Clinical trial simulation. Appl. Clin. Trials 5: 8: 3540, 1996. |
|
|
|
|
|
|
|
|
9. L Brown. ICH GCP and its worldwide implementation. Good Clin. Pract. J. 3: 4: 69, 1996. |
|
|
|
|
|